At twenty-four weeks, the Novolimus eluting coronary stent program demonstrated sustained efficacy and medical safety without incidents of stent thrombosis. Novolimus Eluting Coronary Stent Program with Durable Polymer: EXCELLA II Randomized Clinical Trial Update The EXCELLA II randomized medical trial completed patient enrollment in the initial quarter of 2009. The study enrolled 210 sufferers in European countries and Asia Pacific. Patients are going through the nine-month clinical currently, angiographic, and IVUS follow-up. Data from the trial shall be submitted for CE Mark approval. Serruys, M.D., Ph.D. Of the Thoraxcenter, Erasmus University Hospital, Rotterdam, The Netherlands, principal investigator for the EXCELLA II trial.?..Yes, individuals with this health issue can place order because of this product right at the comfort and ease of their home and this is excatly why it could be stated as the house remedy. What exactly are the conditions treated? This herbal remedy could cure the following issues: 1. Inflammation and Infections in rectum 2. Irritation, pain and itching in anus 3. Piles of whether it’s dry or bleeding piles irrespective 4. Internal and exterior hemorrhoids.